Inhibition of HSV-1 replication and reactivation by the mutation-insensitive transcription inhibitor tetra-O-glycyl-nordihydroguaiaretic acid

Antiviral Research

Volumn 58, Issue 1, 2003, Pages 35-45

  Park, Richard ^a   Giza, Paul E ^a   Mold, David E ^a   Huang, Ru Chih C ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

G4N M4N; Herpes simplex virus type 1; Latency; Sp1; Tetra O glycyl nordihydroguaiaretic acid

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; NORDIHYDROGUAIARETIC ACID; PREGNANCY SPECIFIC BETA1 GLYCOPROTEIN; TETRA O GLYCYLNORDIHYDROGUAIARETIC ACID; UNCLASSIFIED DRUG; WATER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; BINDING SITE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG DETERMINATION; DRUG EFFECT; DRUG SOLUBILITY; GEL MOBILITY SHIFT ASSAY; GENETIC TRANSCRIPTION; HERPES SIMPLEX VIRUS 1; IC 50; LABORATORY; MOUSE; MUTATION; NITROBLUE TETRAZOLIUM TEST; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; REDUCTION; TRIGEMINUS GANGLION; VERO CELL; VIRUS GENE; VIRUS INHIBITION; VIRUS REACTIVATION; VIRUS STRAIN; WILD TYPE;

HUMAN HERPESVIRUS 1; MURINAE; SIMPLEXVIRUS;

EID: 0037367444     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(02)00165-1     Document Type: Article

References (25)

1. Asbell P.A. Valacyclovir for the prevention of recurrent herpes simplex virus eye disease after excimer laser photokeratectomy. Trans. Am. Ophthalmol. Soc. 98:2000;285-303.
2. Chen H., Teng L., Li J., Park R., Mold D.E., Gnabre J., Hwu J.R., Tseng W.N., Huang R.C. Antiviral activities of methylated noridhydroguaiaretic acids. Part 2. Targeting herpes simplex virus replication by the mutation insensitive transcription inhibitor tetra-O-methyl-NDGA. J. Med. Chem. 41:1998;3001-3007.
3. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guianidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
4. Cleary M.A., Herr W. Mechanisms and flexibility in DNA sequence recognition and VP16-induced complex formation by the Oct-1 POU domain. Mol. Cell. Biol. 14:1995;2090-2100.
5. Crumpacker, C., 2001. Antiviral agents. In: Knipe, D.M., Howley, P.M., Griffin, D.E., Lamb, R.A., Martin, M.A., Roizman, B. et al. (Eds.), Fields Virology, 4th edition. Lippincott Williams and Wilkins, Philadelphia, pp. 393-433.
6. Crumpacker C.S., Schnipper L.E., Marlow S.I., Kowalsky P.N., Hershey B.J., Levin M.J. Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir. N. Engl. J. Med. 306:1982;343-346.
7. De Logu A., Loy G., Pellerano M.L., Bonsignore L., Schivo M.L. Inactivation of HSV-1 and HSV-2 and prevention of cell-to-cell virus spread by Santolina insularis essential oil. Antiviral Res. 48:2000;177-185.
8. Efstathiou S., Field H.J., Griffiths P.D., Kern E.R., Sacks S.L., Sawtell N.M., Stanberry L.R. Herpes simplex virus latency and nucleoside analogues. Antiviral Res. 41:1999;85-100.
9. Gilbert S. Improving the outcome of facial resurfacing - prevention of herpes simplex virus type 1 reactivation. J. Antimicrob. Chemother. 47:2001;29-34.
10. Gnabre J.N., Brady J.N., Clanton D.J., Ito Y., Dittmer J., Bates R.B., Huang R.C. Inhibition of human immuno deficiency virus type 1 transcription and replication by DNA sequence-selective plant lignans. Proc. Natl. Acad. Sci. 92:1995;11239-11243.
11. Heller, J.D., 2002. Discovery and mechanism of the anti-cancer chemotherapeutic tetra-O-methyl nordihydroguaiaretic acid. Ph.D. thesis, Johns Hopkins University, UMI Dissertations Publishing.
12. 2 arrest in mammalian cells and exhibits tumoricidal activity in vivo. Cancer Res. 61:2001;5499-5504.
13. Hirsch, M.S., Kaplan, J.C., D'Aquila, R.T., 1996. Antiviral agents. In: Fields, B.N., Knipe, D.M., Howley, P.M., Chanock, R.M., Melnick, J.C., Monath, T.P. et al. (Eds.), Fields Virology, 3rd edition. Raven Press, Philadelphia, pp. 431-466.
14. Huang, R.C., Li, Y., Giza, P.E., Gnabre, J.N., Abd-Elazem, I.S., King, K.Y., Hwu, J.R., 2002. Novel anti-viral agent tetraglycylated nordihydroguaiaretic acid hydrochloride as a host dependent viral inhibitor. Antiviral Res, in press.
15. Jones K.A., Tjian R. Sp1 binds to promoter sequences and activates herpes simplex virus 'immediate-early' gene transcription in vitro. Nature. 317:1985;179-182.
16. Kaplowitz L.G., Baker D., Gelb L., Blythe J.et al. Prolonged continuous acyclovir treatment of normal adults with frequently recurring genital herpes simplex virus infection. J. Am. Med. Assoc. 265:1991;747-751.
17. Khan S.A., Wingard J.R. Infection and mucosal injury in cancer treatment. J. Natl. Cancer Inst. Monogr. 29:2001;31-36.
18. Marin M., Karis A., Visser P., Grosveld F., Philipsen S. Transcription factor Sp1 is essential for early embryonic development but dispensable for cell growth and differentiation. Cell. 89:1997;619-628.
19. 4N. Ph.D. thesis, Johns Hopkins University, UMI Dissertations Publishing.
20. Richman D.D. HIV chemotherapy. Nature. 410:2001;995-1001.
21. Roizman, B., Sears, A.E., 1996. Herpes simplex viruses and their replication. In: Fields, B.N., Knipe, D.M., Howley, P.M., Chanock, R.M., Melnick, J.C., Monath, T.P. et al. (Eds.), Fields Virology, 3rd edition. Raven Press, Philadelphia, pp. 2231-2295.
22. Sjottem E., Andersen C., Johansen T. Structural and functional analyses of DNA bending induced by Sp1 family transcription factors. J. Mol. Biol. 267:1997;490-504.
23. Spector D., Purves F., Roizman B. Role of alpha-transinducing factor (VP16) in the induction of alpha genes within the context of viral genomes. J. Virol. 65:1991;3504-3513.
24. Straten M.V., Carrasco D., Lee P., Tyring S.K. A review of antiviral therapy for herpes labialis. Arch. Dermatol. 137:2001;1232-1235.
25. Whitley, R.J., 1996. Herpes simplex viruses. In: Fields, B.N., Knipe, D.M., Howley, P.M., Chanock, R.M., Melnick, J.C., Monath, T.P. et al. (Eds.), Fields Virology, 3rd edition. Raven Press, Philadelphia.